X, Y., L, X., C, B., D, D., L, C., X, Y., . . . K, S. (2018). Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects. Dove Medical Press.
Style de citation Chicago (17e éd.)X, Yan, Xu L, Bi C, Duan D, Chu L, Yu X, Wu Z, Wang A, et Sun K. Lactoferrin-modified Rotigotine Nanoparticles for Enhanced Nose-to-brain Delivery: LESA-MS/MS-based Drug Biodistribution, Pharmacodynamics, and Neuroprotective Effects. Dove Medical Press, 2018.
Style de citation MLA (8e éd.)X, Yan, et al. Lactoferrin-modified Rotigotine Nanoparticles for Enhanced Nose-to-brain Delivery: LESA-MS/MS-based Drug Biodistribution, Pharmacodynamics, and Neuroprotective Effects. Dove Medical Press, 2018.